Phacilitate

  • About Us
  • Insights and Resources
        • All Insights and Resources
          The latest and greatest Insights Phacilitate has to offer, across all our key sectors and mediums

        • The Phacilitate Podcast
          Insightful conversations with industry leaders

        • Content Services
          We create game-changing content that empowers the advanced therapies industry

          • Industry Insights
            • Clinical Trials
            • Collaborations, Mergers and Acquisitions
            • Finance and Investment
            • GMP
            • Patient Access and Engagement
            • Regulatory and Standards
            • Reimbursement
            • Strategy
          • Manufacturing
            • Automation and Digitisation
            • Characterisation
            • CMC
            • GMP
            • Logistics
            • Partnering
            • Point of Care
            • Raw Materials
            • Scaling Up
            • Skills, Talent and Development
            • Supply Chain
          • Techniques
            • Allogeneic
            • Autologous
            • CAR-X
            • Cell Therapy
            • Gene Editing
            • Gene Therapy
            • NKx
            • Stem Cells
            • Viral/Non-viral Vectors
  • Events
  • Membership
    • Phacilitate Network
    • Advanced Therapies Investor Network
    • Women in Advanced Therapies
  • Latest News
Back
  • About Us
  • Insights and Resources
        • All Insights and Resources
          The latest and greatest Insights Phacilitate has to offer, across all our key sectors and mediums

        • The Phacilitate Podcast
          Insightful conversations with industry leaders

        • Content Services
          We create game-changing content that empowers the advanced therapies industry

          • Industry Insights
            • Clinical Trials
            • Collaborations, Mergers and Acquisitions
            • Finance and Investment
            • GMP
            • Patient Access and Engagement
            • Regulatory and Standards
            • Reimbursement
            • Strategy
          • Manufacturing
            • Automation and Digitisation
            • Characterisation
            • CMC
            • GMP
            • Logistics
            • Partnering
            • Point of Care
            • Raw Materials
            • Scaling Up
            • Skills, Talent and Development
            • Supply Chain
          • Techniques
            • Allogeneic
            • Autologous
            • CAR-X
            • Cell Therapy
            • Gene Editing
            • Gene Therapy
            • NKx
            • Stem Cells
            • Viral/Non-viral Vectors
  • Events
  • Membership
    • Phacilitate Network
    • Advanced Therapies Investor Network
    • Women in Advanced Therapies
  • Latest News
Join Today
Sign In
Sign In
Join Today
  • All Insights and Resources
  • Industry Insights
  • Manufacturing
  • Techniques
Clinical Trials
Collaborations, Mergers and Acquisitions
Finance and Investment
GMP
Patient Access and Engagement
Regulatory and Standards
Reimbursement
Strategy
Automation and Digitisation
Characterisation
CMC
GMP
Logistics
Partnering
Point of Care
Raw Materials
Scaling Up
Skills, Talent and Development
Supply Chain
Allogeneic
Autologous
CAR-X
Cell Therapy
Gene Editing
Gene Therapy
NKx
Stem Cells
Viral/Non-viral Vectors
All News

CAR-X

10 Years of CAR-T: What Does the Future Hold for CAR-T?
20 May 2022
10 Years of CAR-T: What Does the Future Hold for CAR-T?
As our month of celebrating
CAR-T Research – An Interview with UCL’s Claire Roddie
11 May 2022
CAR-T Research – An Interview with UCL’s Claire Roddie
Claire Roddie, Consultant Hematologist at
CAR-T – The Driving Force Behind a Cure for Blood Cancer?
10 May 2022
CAR-T – The Driving Force Behind a Cure for Blood Cancer?
To date all CAR-T cell
CAR-T Research – An Interview with UChicago’s Michael Bishop
5 May 2022
CAR-T Research – An Interview with UChicago’s Michael Bishop
Michael Bishop MD, the Director
POPULAR NEWS ITEMS
Image
20 May 2022

10 Years of CAR-T: What Does the Future Hold for CAR-T?

Image
16 May 2022

ASGCT: Highlights From the Program

Image
18 May 2022

Virica Biotech Receives Funding from Canadian Government to Support the Re-Development of the Worlds First Ever Gene Therapy

10 Years of CAR-T – The Top 10 Milestones
3 May 2022
10 Years of CAR-T – The Top 10 Milestones
We look back over the
10 Years of CAR-T
1 May 2022
10 Years of CAR-T
For this feature, the Phacilitate
Chimeric and WuXi ATU Partner to Advance CAR-T Manufacturing Pipelines
13 April 2022
Chimeric and WuXi ATU Partner to Advance CAR-T Manufacturing Pipelines
Chimeric has announced they have
BioNTech Present Positive Data for First-in-Class CAR-T Program, BNT211, in Advanced Solid Tumours
12 April 2022
BioNTech Present Positive Data for First-in-Class CAR-T Program, BNT211, in Advanced Solid Tumours
BioNTech, presented positive preliminary Phase
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

10 Years of CAR-T: What Does the Future Hold for CAR-T?

Image

ASGCT: Highlights From the Program

Image

Virica Biotech Receives Funding from Canadian Government to Support the Re-Development of the Worlds First Ever Gene Therapy

logo_footer
logo_mobile_footer
Company
  • About Us
  • Events
  • Contact Us
Resources
  • Insights and Resources
  • Latest News
  • Phacilitate Podcast
  • Content Services
Network
  • Sign In
  • Join Today
social_icon Linkedin
social_icon Twitter

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

  • Privacy Policy
  • Code of Conduct
  • Terms & Conditions
  • Cookies
Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022

We use Cookies to improve your experience on our site. Learn More

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close